American Academy of Ophthalmology
- Age-related macular degeneration (AMD): percentage of patients aged 50 years and older with a diagnosis of AMD or their caregiver(s) who were counseled within 12 months on the benefits and/or risks of the Age-Related Eye Disease Study (AREDS) formation for preventing progression of AMD. This updates a previously published measure summary.
- Age-related macular degeneration (AMD): percentage of patients aged 50 years and older with a diagnosis of AMD who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or hemorrhage, AND the level of macular degeneration severity during one or more office visits within 12 months. This updates a previously published measure summary.
- Cataracts: percentage of patients aged 18 years and older with a procedure of cataract surgery with IOL placement who received a comprehensive preoperative assessment of 1) dilated fundus exam; 2) axial length, corneal keratometry measurement, and method of IOL power calculation; and 3) functional or medical indication(s) for surgery prior to the cataract surgery with IOL placement within 12 months prior to cataract surgery. This updates a previously published measure summary.
- Primary open-angle glaucoma (POAG): percentage of patients aged 18 years and older with a diagnosis of POAG or their caregiver who were counseled within 12 months about 1) the potential impact of glaucoma on their visual functioning and quality of life, and 2) the importance of treatment adherence. This updates a previously published measure summary.
- Primary open-angle glaucoma (POAG): percentage of patients aged 18 years and older with a diagnosis of POAG whose glaucoma treatment has not failed (the most recent IOP was reduced by at least 15% from the pre-intervention level) OR if the most recent IOP was not reduced by at least 15% from the pre-intervention level, a plan of care was documented within 12 months. This updates a previously published measure summary
.png)
No hay comentarios:
Publicar un comentario